Table of Contents Table of Contents
Previous Page  19 / 52 Next Page
Information
Show Menu
Previous Page 19 / 52 Next Page
Page Background

© The Canadian Journal of Urology™; 23(Supplement 1); February 2016

BPH update: medical versus interventional

management

Udi Blankstein, MD,

1

Brandon Van Asseldonk, BASc,

2

Dean S. Elterman, MD

2

1

Department of Urology, McMaster University, Hamilton, Ontario, Canada

2

Division of Urology, Department of Surgery, University of Toronto, Toronto, Ontario, Canada

BLANKSTEINU, VANASSELDONKB, ELTERMAN

DS. BPH update: medical versus interventional

management.

Can J Urol

2016;23(Suppl 1):10-15.

Benign prostatic hyperplasia (BPH) is a common

condition that afflicts a large proportion of aging men.

The primary care physician has an important role with the

identification and early treatment of bothersome urinary

symptoms caused by BPH. This includes a detailed history

and physical exam, as well as initiation of a number of

medications such as alpha-blockers, 5-alpha reductase

inhibitors and phosphodiesterase-5 inhibitors. It is also

very important for the primary care giver to determine

when additional evaluation and referral to a urologist

needs to occur, specifically when surgical intervention is

needed. This reviewwill summarize themanagement of this

common disorder and is designed to aid the generalist with

the pertinent information needed to provide excellent care.

Key Words:

BPH, benign prostatic hyperplasia

referred to as BPH-LUTS. Common LUTS can be

subdivided into storage andvoiding symptoms. Storage

LUTS includes frequency, urgencyandnocturia. Voiding

LUTS includes weak stream, hesitancy, intermittent

stream, straining and incomplete emptying. Progression

of BPH can lead to a significant reduction in quality of

life (QoL), and is associatedwithdepression and anxiety

amongst elderly men.

3

Furthermore, if left untreated,

there may be eventual development of urinary

retention, recurrent urinary tract infections (UTIs), and

hydronephrosis. Thus, as common as this condition

is, it is in fact an important issue to recognize, monitor

and treat appropriately. Moreover, as the population

ages, primary care physicians will be encounteringmen

with this problemwith increasing frequency.

4

As such,

the purpose of this article is to familiarize the general

practitioner with the work up and current recognized

treatment options available for BPH.

10

Background

Benignprostatic hyperplasia (BPH) is a commondisease

in men with incidence that increases with age. It is

estimated that 50% of men age 60 or older, and 80%

of men aged 80 or older, suffer from some form of the

disease.

1

BPH involves the growth of the prostate to

a point where the flow of urine is obstructed, causing

bladder outlet obstruction (BOO) and resulting in lower

urinary tract symptoms (LUTS). BPH can physically

obstruct the urethra in addition to causing increased

smooth muscle tone, both of which result in BOO.

2

The combination of benign prostatic hyperplasia and

resulting lower urinary tract symptoms is commonly

Address correspondence to Dr. Dean S. Elterman, Toronto

Western Hospital, Main Pavilion, 8

th

Floor, Room 317, 399

Bathurst Street, Toronto, ON M5T 2S8 Canada